Search - tctmd.com

Displaying 381 - 400 of 2115

Sort: Relevancy | Date

Presentation TCT 2021

A Novel Sirolimus-Eluting Iron-Based Bioresorbable Scaffold Implantation in Single De Novo Coronary Lesions: Two-Year Clinical and Imaging Outcomes from the First in Man Study (IBS-FIM)

Presenter: Runlin Gao

November 05, 2021

Presentation TCT 2021

Disrupt CAD Pooled Eccentric vs Concentric Analysis

Presenter: Ziad Ali

November 05, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

Presentation TCT 2021

REDEFINE: A Prospective, Randomized Evaluation of the ControlRad System to Reduce Radiation Exposure During Cardiac Catheterization Procedures

Presenter: Simon Dixon

November 05, 2021

Presentation TCT 2021

Disrupt CAD III 1yr Data

Presenter: Matthew Price

November 05, 2021

Presentation TCT 2021

Scanning Laser Angioscopy: A New High-Resolution Multimodal Platform for Intravascular Diagnosis and Therapy

Presenter: NULL

November 05, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

Presentation TCT 2021

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Presenter: Nicolas Van Mieghem

November 05, 2021

Presentation TCT 2021

Introduction & MOA Overview

Presenter: Ziad Ali

November 05, 2021

Presentation TCT 2021

Electroanatomical Navigation for Arterial Stenting with Near-Zero X-Ray or Iodine-Based Contrast Medium: Insights from Experimental Data

Presenter: Jean-Francois Dorval

November 05, 2021

Presentation TCT 2021

Con: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Presenter: Sandeep Nathan

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Presenter: Ori Ben-Yehuda

November 05, 2021

Presentation TCT 2021

Pro: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Presenter: Arthur Reshad Garan

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

Presenter: Joanna Chikwe

November 05, 2021

Presentation TCT 2021

4D ICE for Tomorrow

Presenter: Vaikom Mahadevan

November 05, 2021

Presentation TCT 2021

Pro: Should Multivessel PCI Be Performed Acutely in All or Many Patients With Cardiogenic Shock?

Presenter: William W. O'Neill

November 05, 2021

Presentation TCT 2021

Con: Should Multivessel PCI Be Performed Acutely in All or Many Patients With Cardiogenic Shock?

Presenter: Holger Thiele

November 05, 2021

Presentation TCT 2021

My Perspectives: I

Presenter: JoAnn Lindenfeld

November 05, 2021

Presentation TCT 2021

AcuNav Volume ICE for MitraClip

Presenter: Gagan Singh

November 05, 2021

Advertisement

A Novel Sirolimus-Eluting Iron-Based Bioresorbable Scaffold Implantation in Single De Novo Coronary Lesions: Two-Year Clinical and Imaging Outcomes from the First in Man Study (IBS-FIM)

Disrupt CAD Pooled Eccentric vs Concentric Analysis

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

REDEFINE: A Prospective, Randomized Evaluation of the ControlRad System to Reduce Radiation Exposure During Cardiac Catheterization Procedures

Disrupt CAD III 1yr Data

Scanning Laser Angioscopy: A New High-Resolution Multimodal Platform for Intravascular Diagnosis and Therapy

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Introduction & MOA Overview

Electroanatomical Navigation for Arterial Stenting with Near-Zero X-Ray or Iodine-Based Contrast Medium: Insights from Experimental Data

Con: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Pro: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

4D ICE for Tomorrow

Pro: Should Multivessel PCI Be Performed Acutely in All or Many Patients With Cardiogenic Shock?

Con: Should Multivessel PCI Be Performed Acutely in All or Many Patients With Cardiogenic Shock?

My Perspectives: I

AcuNav Volume ICE for MitraClip

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content